3 Biotech Stocks in Danger of Running Out of Cash – Motley Fool

Motley Fool
Galena did supplement its cash with a common stock offering earlier this month consisting of nearly 24.4 million shares as well as nearly 12.2 million warrants with an exercise price of $2.08. The net proceeds from the deal were expected to be $35.4

and more

…read more

Scroll to Top